drug · protein
AWIQLI FLEXTOUCH
updated 5mo agoby $NVO NOVO NORDISK A S🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 4Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for diabetes mellitus and type 2 diabetes mellitus and 1 investigational indication.
targets
Insulin receptor
all catalysts(0)
nothing on the calendar yet
Trials studying AWIQLI FLEXTOUCH
- —A Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec
- —Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec
- —A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar
- phase1Clinical Trials of IBI3035 in Healthy Subjects
- phase3A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before
- phase3A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- phase3A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
- phase3A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
News(1)
- Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalryThe weekly insulin Onswik will now be available to U.S. patients after initial approvals in Europe, Mexico and Japan.biospace · 4h ago
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that